
Opinion|Videos|November 29, 2024
Case 3: Persistently Active Central Retinal Vein Occlusion
Key Takeaways
In the third case, moderator Lisa J. Faia, MD presents her case of persistently active central retinal vein occlusion (CRVO), explaining her approach to switching this treatment-resistant patient to a newer agent.
Advertisement
Episodes in this series

Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics
2
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
3
Five-year GALE study data announced
4
When policy meets parenthood: Examining residency leave in ophthalmology
5




















































.png)


